
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
WDR36 CRISPR/Cas9 KO Plasmid (h) | sc-410298 | 20 µg | $397.00 |
WDR36 (WD repeat domain 36) encodes a nucleolar WD-repeat protein implicated in ribosome biogenesis and pre-rRNA processing, supporting maturation of the 18S rRNA and assembly of the small ribosomal subunit. Through its role in nucleolar function and RNA metabolism, WDR36 influences proteostasis and cellular growth programs that depend on efficient translation. Genetic variation and altered WDR36 function have been associated with ocular phenotypes including primary open-angle glaucoma, motivating mechanistic studies in relevant cell types. Disruption of WDR36 can also be used to probe how perturbations in ribosome production engage nucleolar stress responses and downstream signaling.
WDR36 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the WDR36 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the WDR36 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the WDR36 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish WDR36 protein expression.
This CRISPR knockout system enables efficient generation of WDR36-deficient cell models for investigation of WDR36 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.